ProPhase Labs Inc (PRPH)

[Timing101]

$PRPH New COO Stu Hollingshead is a PRO on Company Growth with Proven Background. Just came on board end of Feb 2025 for a REASON , CEO Ted K has a winning partner in this filed and Stu is invested.
--
See Stu Hollingshead background here ( DD SPOT ON)
https://www.linkedin.com/in/hollenshead/
--
With the new streamlined Prophase Labs and revenue coming in from Receivables (at least 30 million per CEO of the 150 Million on record) , it will give someone like Stu H the ability to assist. See his Post on his linked in. Quote
" BUT as of February 18th I am simultaneously going to step in as the COO over at ProPhase Labs, a next-gen biotech, genomics, and consumer products company.

This marks the first time I may be able to properly leverage my degrees in biochemistry and cellular biology…

Originally a 10PM Curfew partner by way of DNAcomplete .com, working with the team over the past several months has solidified my conviction that they have significant upside potential across the entire organization.

Over the past year they got themselves into a very tough spot at both the macro and micro level, but with the potential of a strong cash infusion on the horizon, ProPhase will be ready to scale.

The perfect inflection point to build world-class consumer brands within the health, wellness and longevity space is on that same horizon.

The opportunity is massive IF we are strategic, patient and execute well. And I would be foolish to not admit that in all success there’s a little bit of luck and good timing.

We’re going to need all of that.

At the fundamental level, what appeals to me about this opportunity is that the company-owned intellectual property is very, very high potential.

- DNAComplete. com powered by Nebula Genomics which is a leading direct-to-consumer whole genome sequencing provider with a significant database of over 65,000 whole genome sequenced customers (equivalent in size to more than 150 million typical ancestry tests) is a powerful D2C business with a B2B revenue stream. This business has incredibly high potential but I’m thinking we need to simplify operations as quickly as possible and this could be one area we part ways with in the near future. Its standalone value is validated by way of Nucleus Genomics (a very similar business) raising $14-million in Series A funding from Seven Six, Founders Fund, Neo, One Eight Capital, Giant Step, Common Metal, Asylum Ventures, Rose Street Capital, Balaji Srinivasan, Amanda Bradford and many others. Send potential buyers my way.

- Legendz is a scientifically backed proprietary blend of ingredients that can and will appeal to the male demographic within the D2C space. It currently is already available in retail but just has never had an online strategy. Look for this to launch online in the near future.

- Equivir - another scientifically backed proprietary blend centered around virus-shortening and immunity-boosting - should be coming at the end of the year. I’m very excited about this one.

- A bit more of a moonshot is the BE-Smart esophageal cancer test. The Company has determined that the target market for this potential lifesaving cancer diagnostic test is $7 - $14 billion, in the U.S. alone, and has minimal competition at present.

Putting aside the existing IP - I’m going to be hunting for strategic partnerships and joint ventures. If you have any ideas you’d like to put in front of me, I’d love to hear them. Hit me up anytime.